ATE32214T1 - Diarylindan-1,3-dione, deren herstellung und verwendung. - Google Patents

Diarylindan-1,3-dione, deren herstellung und verwendung.

Info

Publication number
ATE32214T1
ATE32214T1 AT84201452T AT84201452T ATE32214T1 AT E32214 T1 ATE32214 T1 AT E32214T1 AT 84201452 T AT84201452 T AT 84201452T AT 84201452 T AT84201452 T AT 84201452T AT E32214 T1 ATE32214 T1 AT E32214T1
Authority
AT
Austria
Prior art keywords
diones
diarylindan
preparation
arylindane
inflammatories
Prior art date
Application number
AT84201452T
Other languages
English (en)
Inventor
Alexander Cupples Campbell
Donald Fraser Melven Stevenson
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Application granted granted Critical
Publication of ATE32214T1 publication Critical patent/ATE32214T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C63/00—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
    • C07C63/33—Polycyclic acids
    • C07C63/331—Polycyclic acids with all carboxyl groups bound to non-condensed rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/45—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/56—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
    • C07C45/57—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom
    • C07C45/59—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom in five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/63—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/64—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of functional groups containing oxygen only in singly bound form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/657—Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings
    • C07C49/665—Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings a keto group being part of a condensed ring system
    • C07C49/67—Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings a keto group being part of a condensed ring system having two rings, e.g. tetralones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/687—Unsaturated compounds containing a keto groups being part of a ring containing halogen
    • C07C49/697—Unsaturated compounds containing a keto groups being part of a ring containing halogen containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/747—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • C07C49/755—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups a keto group being part of a condensed ring system with two or three rings, at least one ring being a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C61/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C61/16—Unsaturated compounds
    • C07C61/39—Unsaturated compounds containing six-membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pens And Brushes (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Indole Compounds (AREA)
  • Steroid Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Medicinal Preparation (AREA)
AT84201452T 1983-10-14 1984-10-10 Diarylindan-1,3-dione, deren herstellung und verwendung. ATE32214T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB838327598A GB8327598D0 (en) 1983-10-14 1983-10-14 Pharmacologically active diarylindane-13-diones
EP84201452A EP0138272B1 (de) 1983-10-14 1984-10-10 Diarylindan-1,3-dione, deren Herstellung und Verwendung

Publications (1)

Publication Number Publication Date
ATE32214T1 true ATE32214T1 (de) 1988-02-15

Family

ID=10550228

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84201452T ATE32214T1 (de) 1983-10-14 1984-10-10 Diarylindan-1,3-dione, deren herstellung und verwendung.

Country Status (16)

Country Link
US (1) US4569945A (de)
EP (1) EP0138272B1 (de)
JP (1) JPS60109541A (de)
KR (1) KR920003101B1 (de)
AT (1) ATE32214T1 (de)
AU (1) AU561309B2 (de)
CA (1) CA1245232A (de)
DE (1) DE3469020D1 (de)
DK (1) DK491984A (de)
ES (1) ES8602582A1 (de)
FI (1) FI82923C (de)
GB (1) GB8327598D0 (de)
GR (1) GR80629B (de)
HU (1) HUT35627A (de)
PT (1) PT79356B (de)
ZA (1) ZA847967B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2556966B1 (fr) * 1983-12-26 1987-09-25 Bouchard Sa Laboratoires Nouvelle application therapeutique d'un derive de l'indane dione et les compositions pharmaceutiques destinees a cet usage
FR2593501B1 (fr) * 1986-01-29 1988-05-06 Panmedica Sa Nouveaux derives bis (r-oxyimino)-5,7 dihydro-6,7 (5h) dibenzo (a,c) cycloheptene, leurs procedes de preparation et leur application comme medicaments
JP2582898B2 (ja) * 1989-05-16 1997-02-19 三菱化学株式会社 インダン―１，３―ジオン誘導体およびこれを有効成分とする除草剤
JP5941142B2 (ja) * 2011-06-16 2016-06-29 コーリア リサーチ インスティテュート オブ ケミカル テクノロジー １，３−ジオキソインデン誘導体、その薬学的に許容される塩又は光学異性体、その調製方法及びそれを抗ウイルス活性成分として含有する医薬組成物
PL3882244T3 (pl) 2012-12-14 2025-06-16 Korea Research Institute Of Chemical Technology ZWIĄZEK, JEGO FARMACEUTYCZNIE DOPUSZCZALNA SÓL LUB IZOMER OPTYCZNY, SPOSÓB ICH WYTWARZANIA i ZAWIERAJĄCA JE, JAKO SKŁADNIK AKTYWNY, KOMPOZYCJA FARMACEUTYCZNA DO PROFILAKTYKI LUB LECZENIA CHORÓB WIRUSOWYCH
US12286423B2 (en) 2020-04-20 2025-04-29 Novartis Ag Antiviral 1,3-di-oxo-indene compounds
CA3176727A1 (en) 2020-04-20 2021-10-28 Novartis Ag Antiviral 1,3-di-oxo-indene compounds

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2361517A (en) * 1939-09-22 1944-10-31 Gen Electric Sealing apparatus
DE947473C (de) * 1953-04-30 1956-08-16 Geigy Ag J R Verfahren zur Herstellung von 2-(p-Chlorphenyl)-indan-1, 3-dion
DE1130439B (de) * 1960-06-27 1962-05-30 Us Vitamin Pharm Corp Verfahren zur Herstellung von 2-Arylindandionen
NL128364C (de) * 1964-08-27
GB1172696A (en) * 1966-10-20 1969-12-03 Koninklijke Pharma Fab Nv Phenyl-Indandione Derivatives
US3784606A (en) * 1968-08-29 1974-01-08 Pfizer Novel 2-aryl-1,3-indandiones and 2-aryl-2,3-dihydrobenz(f)indene-1,3-diones
US3803240A (en) * 1969-04-14 1974-04-09 Union Carbide Corp 2-(2,6-substituted-phenyl)-1,3-indandiones
US3879468A (en) * 1969-04-14 1975-04-22 Union Carbide Corp 2-(poly substituted phenyl)-1,3-indandione compounds
US3784605A (en) * 1971-05-13 1974-01-08 Union Carbide Corp 2-(polysubstituted phenyl)-1,3-indandione compounds
GB1380089A (en) * 1972-01-20 1975-01-08 Istituto Gentilipisa Spa 2-aryl-1,3-indandiones
US3978231A (en) * 1972-01-25 1976-08-31 Beecham Group Limited Pharmaceutical compositions and method of treating allergic conditions utilizing 2-nitroindane-1,3-dione derivatives as the active agents
US3976681A (en) * 1973-10-12 1976-08-24 Merck & Co., Inc. [1,3-Dioxo-2-substituted and 2,2-disubstituted- indanyloxy (or thio] alkanoic acids
FR2392951A2 (fr) * 1975-02-07 1978-12-29 Creat Lab Nouveaux derives de la ninhydrine, leurs procedes de preparation et medicaments contenant ces derives

Also Published As

Publication number Publication date
HUT35627A (en) 1985-07-29
FI844020L (fi) 1985-04-15
FI82923C (fi) 1991-05-10
PT79356A (en) 1984-11-01
KR920003101B1 (ko) 1992-04-18
ES536743A0 (es) 1985-11-16
KR850003382A (ko) 1985-06-17
AU561309B2 (en) 1987-05-07
DK491984A (da) 1985-04-15
FI844020A0 (fi) 1984-10-12
ZA847967B (en) 1985-05-29
GR80629B (en) 1985-02-12
JPS60109541A (ja) 1985-06-15
AU3418484A (en) 1985-04-18
ES8602582A1 (es) 1985-11-16
DE3469020D1 (en) 1988-03-03
CA1245232A (en) 1988-11-22
US4569945A (en) 1986-02-11
EP0138272A1 (de) 1985-04-24
FI82923B (fi) 1991-01-31
PT79356B (en) 1986-09-08
EP0138272B1 (de) 1988-01-27
GB8327598D0 (en) 1983-11-16
DK491984D0 (da) 1984-10-12

Similar Documents

Publication Publication Date Title
DE3687362D1 (de) Mischungen von fluorenthaltendem polymer, deren herstellung und anwendung.
IT1191150B (it) Virus vaccinico modificato e metodi per la produzione ed uso del medesimo
DE3382271D1 (de) 2,4-dihalo-5-nitrophenyl-4,5,6,7-tetrahydro-2h-indazole, deren herstellung und anwendung.
ATE35416T1 (de) Derivate des glycerophosphocholins und glycerophosphoethanolamins, ihre herstellung und verwendung.
DE69523654D1 (de) Verwendung von Ascorbyl-gamma-Linolenat und von Ascorbyl-dihomo-gamma-linolenat zur Behandlung von Asthma, Krebs, kardiovaskulären und inflammatorischen Erkrankungen
ATE1500T1 (de) 6-chlor-2,3-dihydroxy-1,4-naphthochinon und seine 2,3-diester, und ihre herstellung.
BR7900905A (pt) Aparelho para o saneamento de liquidos com irradiacao ultravioleta e ozonio
ATE113207T1 (de) Benzamid gegen kognitive erkrankungen.
AU561309B2 (en) Diarylindane-1,3-diones
ES2184774T3 (es) Bifenil-2,2'-diil-bis-difenilfosfinas halogenadas, su preparacion y empleo.
ATE39694T1 (de) (pyrrol-1-yl)-phenyl-dihydropyridazinone, ihre herstellung und verwendung.
FI830523L (fi) Anti-inflammatoriska och/eller smaerta lindrande 2,3-diaryl-5-halotiofener
ATA349383A (de) Waessrige wachsdispersionen, deren herstellung und verwendung
ATE45675T1 (de) Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen.
ATE40782T1 (de) Herstellung von vorkaese und kaese mit hoher trockenmasse.
IT8319600A0 (it) Composizioni farmaceutiche e loro uso nel trattamento del glaucoma.
ATE89569T1 (de) Haemoglobin mit reduziertem virusrisiko und dessen herstellung.
DE69116216D1 (de) Verwendung von Squalene, Squalane oder deren Mischungen zur Herstellung einer abkühlenden Zusammensetzung zur örtlichen Behandlung von Verbrennungen
IT7819623A0 (it) Composizione adatta alla purificazione del sangue e suoi impieghi.
DE3772237D1 (de) Herstellung von sekundaeraminen aus olefinen und primaeraminen.
ATE75727T1 (de) Noremopamil, seine herstellung und verwendung.
JPS5517393A (en) Nncyclohexyllnnmethoxyacetoacetoamide*and its use for manufacturing oomethyllnncyclohexyll 2*55dimethylfurann33hydroxamic acid
ATE9757T1 (de) Verfahren zur herstellung von antioxydantien und deren verwendung.
IT1147764B (it) M -2-one contenenti nelle posizioni 3-e5-centri di asimmetria con la medesima configurazione assoluta e procedimento per la loro preparazione
ATE710T1 (de) Dielektrische fluessigkeiten, verfahren zur herstellung und anwendungen.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties